Page last updated: 2024-09-05

lenalidomide and warfarin

lenalidomide has been researched along with warfarin in 7 studies

Compound Research Comparison

Studies
(lenalidomide)
Trials
(lenalidomide)
Recent Studies (post-2010)
(lenalidomide)
Studies
(warfarin)
Trials
(warfarin)
Recent Studies (post-2010) (warfarin)
3,5327252,85036,5732,14314,728

Protein Interaction Comparison

ProteinTaxonomylenalidomide (IC50)warfarin (IC50)
Vitamin K epoxide reductase complex subunit 1 Homo sapiens (human)0.0088

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Anderson, KC; Attal, M; Barlogie, B; Belch, A; Bladé, J; Boccadoro, M; Bringhen, S; Cavo, M; Dimopoulos, MA; Durie, BG; Harousseau, J; Hussein, MA; Joshua, D; Knop, S; Kyle, R; Lonial, S; Ludwig, H; Morgan, GJ; Niesvizky, R; Orlowski, RZ; Palumbo, A; Rajkumar, SV; Richardson, PG; San Miguel, J; Sezer, O; Shimizu, K; Sonneveld, P; Vesole, D; von Lilienfeld-Toal, M; Waage, A; Weber, D; Westin, J; Zangari, M; Zonder, JA1
Gajra, A; Singh, A1
Brioli, A; Cavo, M; Pantani, L; Tacchetti, P; Zamagni, E; Zannetti, B1
Alexander, M; Kirsa, S; Lingaratnam, S; Mellor, JD; Teoh, KC1
Chen, N; Knight, R; Palmisano, M; Weiss, D; Zhou, S1
Leebeek, FW1

Reviews

4 review(s) available for lenalidomide and warfarin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
    Leukemia, 2008, Volume: 22, Issue:2

    Topics: Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Premedication; Risk Assessment; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin

2008
Thromboembolism with immunomodulatory agents in the treatment of multiple myeloma.
    Cardiovascular & hematological agents in medicinal chemistry, 2011, Volume: 9, Issue:1

    Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Thalidomide; Thromboembolism; Warfarin

2011
Update of thrombosis in multiple myeloma.
    Thrombosis research, 2016, Volume: 140 Suppl 1

    Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; Lenalidomide; Multiple Myeloma; Thalidomide; Thrombosis; Warfarin

2016

Trials

1 trial(s) available for lenalidomide and warfarin

ArticleYear
Evaluation of pharmacokinetic and pharmacodynamic interactions when lenalidomide is co-administered with warfarin in a randomized clinical trial setting.
    Clinical drug investigation, 2015, Volume: 35, Issue:7

    Topics: Adult; Anticoagulants; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Humans; Immunologic Factors; International Normalized Ratio; Lenalidomide; Male; Middle Aged; Prothrombin Time; Thalidomide; Warfarin; Young Adult

2015

Other Studies

2 other study(ies) available for lenalidomide and warfarin

ArticleYear
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.
    Seminars in thrombosis and hemostasis, 2011, Volume: 37, Issue:3

    Topics: Activated Protein C Resistance; Aged; Anticoagulants; Aspirin; Boronic Acids; Bortezomib; Dexamethasone; Humans; Immunologic Factors; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin

2011
Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospital.
    Asia-Pacific journal of clinical oncology, 2013, Volume: 9, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Cancer Care Facilities; Enoxaparin; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Practice Patterns, Physicians'; Prognosis; Retrospective Studies; Specialization; Thalidomide; Thrombosis; Warfarin

2013